AI-generated from publicly available materials.A groundbreaking collaboration between IMU Biosciences and the UK Biobank aims to create an extensive and detailed map of the human immune system, leveraging advanced technologies and AI methodologies.
The initiative seeks to enhance the UK Biobank's existing dataset by adding high-resolution immune data, generating over 100 million immune data points from tens of thousands of samples. This will result in the most comprehensive immune dataset to date. The project utilizes IMU’s HD Immunology platform alongside Waters Corporation's advanced flow cytometry and multiomic tools, including the BD FACSDiscover Cell Analyzer and the BD Rhapsody platform. Ultima Genomics will contribute its UG200 Sequencing Platform to facilitate large-scale data collection.
Starting this year, the project will initially profile blood samples from 80,000 participants, with plans to expand to the full UK Biobank cohort of 500,000. The resulting immune data will be essential for researchers investigating the relationship between immune variations and various health outcomes, including disease risk and treatment responses.
This collaboration not only promises to advance our understanding of immune system dynamics as people age but also aims to identify specific immune changes linked to diseases like cancer and diabetes. Such insights could lead to earlier detection and more personalized treatment options, showcasing the potential of integrating large-scale biobank data with advanced immune profiling techniques.